Viewing Study NCT00049127


Ignite Creation Date: 2025-12-25 @ 5:07 AM
Ignite Modification Date: 2025-12-26 @ 4:11 AM
Study NCT ID: NCT00049127
Status: COMPLETED
Last Update Posted: 2019-10-21
First Post: 2002-11-12
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Sponsor: Alliance for Clinical Trials in Oncology
Organization: